McDougal, Kathryn E; Fallin, M Daniele; Moller, David R et al. (2009) Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis. J Invest Dermatol 129:1921-6 |
Wasfi, Y S; Silveira, L J; Jonth, A et al. (2008) Fas promoter polymorphisms: genetic predisposition to sarcoidosis in African-Americans. Tissue Antigens 72:39-48 |
Zheng, Gang; Tian, Xin; ACCESS Research Group (2006) Robust trend tests for genetic association using matched case-control design. Stat Med 25:3160-73 |
Baughman, R P; Judson, M A; Teirstein, A et al. (2006) Presenting characteristics as predictors of duration of treatment in sarcoidosis. QJM 99:307-15 |
Barnard, Juliana; Rose, Cecile; Newman, Lee et al. (2005) Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS). J Occup Environ Med 47:226-34 |
Rybicki, Benjamin A; Walewski, Jose L; Maliarik, Mary J et al. (2005) The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 77:491-9 |
Kreider, Mary Elizabeth; Christie, Jason D; Thompson, Bruce et al. (2005) Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 128:207-15 |
Newman, Lee S; Rose, Cecile S; Bresnitz, Eddy A et al. (2004) A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170:1324-30 |
Rabin, D L; Thompson, B; Brown, K M et al. (2004) Sarcoidosis: social predictors of severity at presentation. Eur Respir J 24:601-8 |
Judson, Marc A; Baughman, Robert P; Thompson, Bruce W et al. (2003) Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 20:204-11 |
Showing the most recent 10 out of 15 publications